<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP11744024B8W1" file="EP11744024W1B8.xml" lang="en" country="EP" doc-number="2606061" kind="B8" correction-code="W1" date-publ="20170927" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 0.1.63 (23 May 2017) -  2999001/0</B007EP></eptags></B000><B100><B110>2606061</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20170927</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>11744024.8</B210><B220><date>20110816</date></B220><B240><B241><date>20130318</date></B241><B242><date>20140604</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>374199 P</B310><B320><date>20100816</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20170927</date><bnum>201739</bnum></B405><B430><date>20130626</date><bnum>201326</bnum></B430><B450><date>20170809</date><bnum>201732</bnum></B450><B452EP><date>20170221</date></B452EP><B480><date>20170927</date><bnum>201739</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  14/435       20060101AFI20120306BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>BINDUNGSPROTEINE FÜR HEPCIDIN</B542><B541>en</B541><B542>BINDING PROTEINS FOR HEPCIDIN</B542><B541>fr</B541><B542>PROTÉINES SE LIANT À L'HEPCIDINE</B542></B540><B560><B561><text>WO-A1-2009/058797</text></B561><B561><text>WO-A2-03/029463</text></B561><B561><text>WO-A2-2006/056464</text></B561><B562><text>Anonymous: "Pieris Announces Preclinical In Vitro and In Vivo Data for its Anticalin® PRS-080 Hepcidin Antagonist Drug Program", Pieris AG: News and Events , 23 May 2011 (2011-05-23), XP002661794, Retrieved from the Internet: URL:http://www.pieris-ag.com/news-events/2 001-05-23-Pieris-Announces-Preclinical-In- Vitro-and-In-Vivo-Data.php [retrieved on 2011-10-20]</text></B562><B562><text>GEBAUER M ET AL: "Engineered protein scaffolds as next-generation antibody therapeutics", CURRENT OPINION IN CHEMICAL BIOLOGY, vol. 13, no. 3, 1 June 2009 (2009-06-01), pages 245-255, XP026285197, CURRENT BIOLOGY LTD, LONDON, GB ISSN: 1367-5931, DOI: 10.1016/J.CBPA.2009.04.627 [retrieved on 2009-06-06]</text></B562><B562><text>D. SCHONFELD ET AL: "An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 106, no. 20, 19 May 2009 (2009-05-19) , pages 8198-8203, XP055010048, ISSN: 0027-8424, DOI: 10.1073/pnas.0813399106</text></B562><B562><text>JOLANTA MALYSZKO ET AL: "Neutrophil Gelatinase-Associated Lipocalin and Hepcidin: What Do They Have in Common and Is There a Potential Interaction?", KIDNEY AND BLOOD PRESSURE RESEARCH, vol. 33, no. 2, 1 January 2010 (2010-01-01), pages 157-165, XP055010065, ISSN: 1420-4096, DOI: 10.1159/000315436</text></B562><B562><text>SKERRA A: "'ANTICALINS': A NEW CLASS OF ENGINEERED LIGNAD-BINDING PROTEINS WITH ANTIBODY-LIKE PROPERTIES", REVIEWS IN MOLECULAR BIOTECHNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 74, no. 4, 1 June 2001 (2001-06-01), pages 257-275, XP001079016, ISSN: 1389-0352, DOI: 10.1016/S1389-0352(01)00020-4 cited in the application</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>17185231.2</anum></dnum><date>20170808</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>TRENTMANN, Stefan</snm><adr><str>Finkenweg 23a</str><city>85391 Allershausen</city><ctry>DE</ctry></adr></B721><B721><snm>MATSCHINER, Gabriele</snm><adr><str>Gabelsbergerstr. 70</str><city>80333 Muenchen</city><ctry>DE</ctry></adr></B721><B721><snm>SKERRA, Arne</snm><adr><str>Max-Lehner-Str. 19</str><city>85354 Freising</city><ctry>DE</ctry></adr></B721><B721><snm>HUELSMEYER, Martin</snm><adr><str>Rosenstrasse 18</str><city>85395 Wolfersdorf</city><ctry>DE</ctry></adr></B721><B721><snm>GILLE, Hendrik</snm><adr><str>Volkartstrasse 28</str><city>80634 München</city><ctry>DE</ctry></adr></B721><B721><snm>JENSEN, Kristian</snm><adr><str>Altstadt 357</str><city>84028 Landshut</city><ctry>DE</ctry></adr></B721><B721><snm>BEL AIBA, Rachida Siham</snm><adr><str>Erhardtstrasse 15</str><city>80469 München</city><ctry>DE</ctry></adr></B721><B721><snm>CHRISTIAN, Hans-Juergen</snm><adr><str>Thalbacher Strasse 49a</str><city>85368 Moosburg</city><ctry>DE</ctry></adr></B721><B721><snm>HOHLBAUM, Andreas</snm><adr><str>Schuckelbergstrasse 5</str><city>85307 Paunzhausen</city><ctry>DE</ctry></adr></B721></B720><B730><B731><snm>Pieris Pharmaceuticals GmbH</snm><iid>101601511</iid><irf>PIE14047PCT/EP</irf><adr><str>Lise-Meitner-Strasse 30</str><city>85354 Freising-Weihenstephan</city><ctry>DE</ctry></adr></B731></B730><B740><B741><snm>Schiweck, Weinzierl &amp; Koch 
Patentanwälte Partnerschaft mbB</snm><iid>101223256</iid><adr><str>Landsberger Straße 98</str><city>80339 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>EP2011064086</anum></dnum><date>20110816</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2012022742</pnum></dnum><date>20120223</date><bnum>201208</bnum></B871></B870><B880><date>20130626</date><bnum>201326</bnum></B880></B800></SDOBI>
</ep-patent-document>
